問卷

TPIDB > Principal Investigator

Principal Investigator


Chi Mei Medical Center (在職)

Division of Urology

Division of Hematology & Oncology

MacKay Memorial Hospital (在職)

Division of General Surgery

Division of General Surgery

Chi Mei Medical Center (在職)

Division of Urology

MacKay Memorial Hospital

Division of General Surgery

更新時間:2023-09-19

劉建良
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2014-11-06 - 2024-09-30

Phase III

Completed
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) plus LY2835219, a CDK4/6 Inhibitor, or Placebo in Postmenopausal Women with Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer with No Prior Systemic Therapy in this Disease Setting
  • Condition/Disease

    Hormone Receptor-Positive, HER2-Negative Locoregionally Recurrent or Metastatic Breast Cancer

  • Test Drug

    LY2835219

Participate Sites
8Sites

Terminated7Sites

Study ended1Sites

王惠暢
China Medical University Hospital

Division of General Surgery